Bio-Rad Laboratories, Inc. (BIO) Misses Q1 EPS by 16c
Tweet
Share
E-mailGet Alerts BIO Hot Sheet
Price: $279.04 -1.2%
Revenue Growth %: -4.3%
Financial Fact:
Income before income taxes: 26.86M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: -4.3%
Financial Fact:
Income before income taxes: 26.86M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Bio-Rad Laboratories, Inc. (NYSE: BIO) reported Q1 EPS of $1.16, $0.16 worse than the analyst estimate of $1.32. Revenue for the quarter came in at $485.1 million versus the consensus estimate of $482.11 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ennis (EBF) Reports In-Line Q1 EPS
- CarMax beats estimates as new strategy drives early results
- PowerFleet, Inc. (AIOT) Misses Q1 EPS by 2c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
